Blueprint Medicines
BPMC
#2489
Rank
โ‚ฌ4.92 B
Marketcap
77,11ย โ‚ฌ
Share price
1.82%
Change (1 day)
-8.82%
Change (1 year)

EPS for Blueprint Medicines (BPMC)

EPS in 2023 (TTM): -8,54ย โ‚ฌ

According to Blueprint Medicines 's latest financial reports the company's current EPS (TTM) is -8,08ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -8,22ย โ‚ฌ an increase over its 2021 EPS that were of -9,66ย โ‚ฌ.

EPS history for Blueprint Medicines from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-8,54ย โ‚ฌ3.78%
2022-8,22ย โ‚ฌ-14.85%
2021-9,66ย โ‚ฌ-297.13%
20204,90ย โ‚ฌ-176.3%
2019-6,42ย โ‚ฌ35.19%
2018-4,75ย โ‚ฌ38.82%
2017-3,42ย โ‚ฌ47.35%
2016-2,32ย โ‚ฌ9.25%
2015-2,13ย โ‚ฌ-31.35%
2014-3,10ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-0,06157ย โ‚ฌ-99.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-0,24ย โ‚ฌ-97.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-1,12ย โ‚ฌ-86.18%๐Ÿ‡บ๐Ÿ‡ธ USA